|
|
|
|
|
|
|
||
© The Rockefeller University Press,
0021-9525/2000//413 $5.00
The Journal of Cell Biology, Volume 151, Number 2,
, 2000 413-424
Original Article |
Evidence That the Transition of HIV-1 Gp41 into a Six-Helix Bundle, Not the Bundle Configuration, Induces Membrane Fusion
Many viral fusion proteins exhibit a six-helix bundle as a core structure. HIV Env–induced fusion was studied to resolve whether membrane merger was due to the transition into the bundle configuration or occurred after bundle formation. Suboptimal temperature was used to arrest fusion at an intermediate stage. When bundle formation was prevented by adding inhibitory peptides at this stage, membranes did not merge upon raising temperature. Inversely, when membrane merger was prevented by incorporating lysophosphatidylcholine (LPC) into cell membranes at the intermediate, the bundle did not form upon optimizing temperature. In the absence of LPC, the six-helix bundle did not form when the temperature of the intermediate was raised for times too short to promote fusion. Kinetic measures showed that after the temperature pulse, cells had not advanced further toward fusion. The latter results indicate that bundle formation is the rate-limiting step between the arrested intermediate and fusion. Electrical measures showed that the HIV Env–induced pore is initially large and grows rapidly. It is proposed that bundle formation and fusion are each contingent on the other and that movement of Env during its transition into the six-helix bundle directly induces the lipid rearrangements of membrane fusion. Because peptide inhibition showed that, at the intermediate stage, the heptad repeats of gp41 have become stably exposed, creation of the intermediate could be of importance in drug and/or vaccine development.
Key Words: fusion pore • fusion intermediates • inhibitory peptides • fusion kinetics • hemifusion
© 2000 The Rockefeller University Press
The online version of this article contains supplemental material.Abbreviations used in this paper: CMAC, 7-amino-4-chloromethylcoumarin; CXCR4, chemokine receptor; DiI, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate; HA, hemagglutinin; HR, heptad repeat; IR, infrared; LAS, lipid-arrested stage; LPC, lysophosphatidylcholine; OA, oleic acid; SNARE, soluble N-ethylmaleimide–sensitive factor attachment protein receptor; TAS, temperature-arrested stage; TM, transmembrane.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Facebook 
Reddit 
Technorati 
Twitter What's this?
Related Article
This article has been cited by other articles:
|
|
